Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. (Q48410030)

11 February 2018

title

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. (English)

1 reference

11 February 2018

Adaptive radiation therapy

main subject

0 references

patient

0 references

hepatocellular carcinoma

1 reference

Jinsil Seong

1

1 reference

11 February 2018

Hee Chul Park

series ordinal

2

1 reference

11 February 2018

Kwang Hyub Han

series ordinal

3

1 reference

11 February 2018

Chae Yoon Chon

series ordinal

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 February 2003

1 reference

11 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

11 February 2018

volume

55

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

329-336

1 reference

11 February 2018

Treatment of small hepatocellular carcinomas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Treatment of hepatocellular carcinoma: too many options?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Proton irradiation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

Hepatocellular carcinoma in Central Europe: prognostic features and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

The use of active breathing control (ABC) to reduce margin for breathing motion

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903929-9

7 January 2021

10.1016/S0360-3016(02)03929-9

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018